Coronavirus Updates

March 18, 2021

Countries halting AstraZeneca vaccine

Uganda will import five million doses of AstraZeneca vaccines next month after the discovery of new COVID-19 variants in the country, President Yoweri Museveni has said. In a televised address to the nation late Friday, Museveni said the vaccines will be used to vaccinate at least 80 per cent of the 5.5 million elderly. People below 50 years, with underlying medical conditions that are at high risk of contracting the novel coronavirus, will also be vaccinated. Uganda targets to vaccinate more than 21.9 million people who face the highest risk of the infection, including the health workers, teachers, social workers and security personnel, elderly and those with underlying medical conditions. “The government is working hard to ensure we bring another five million doses of AstraZeneca vaccine before the end of May to complete the threshold vaccination and ensure that those vaccinated before getting the second booster dose,’’ said Museveni. “Vaccines are the most effective intervention we have against COVID-19. “The government and partners are working hard to bring vaccines to most adult Ugandans to protect them and to support us to reopen the economy and get back all our children to school.’’ Henry Mwebesa, Director-General of Health Services, last week said Uganda is scheduled to receive some two million more doses of the AstraZeneca COVID-19 vaccines in May through the COVAX facility. Uganda has so far received 964,000 doses of AstraZeneca vaccines from the COVAX vaccine sharing programme and the Indian government. As of April 16, a total of 220,893 people had been inoculated with the first jab of AstraZeneca vaccine against COVID-19, according to the Ministry of Health statistics. The country has reported the emergence of the highly transmissible COVID-19 variants which were first reported in Britain, South Africa and Nigeria. The ministry’s data showed that as of April 16, Uganda had registered a cumulative total of 41,340 confirmed COVID-19 cases, with 40,898 recoveries and 338 deaths.

More than a dozen countries including France, Italy and Germany have suspended AstraZeneca’s Covid-19 shots because of fears over blood clots and other possible side effects.

While the company insists there is no risk — and World Health Organization experts recommend the continued use of the vaccine — the European Medicines Agency will meet Thursday to decide on “further actions”.

Here is a recap:

– Nordics sound alarm –

Denmark on March 1 becomes the first country to say it will suspend use of the AstraZeneca vaccine as a precautionary measure over fears of blood clots in vaccinated people.

Iceland and Norway follow and announce they are temporarily suspending use.

This comes after Austria stops using a batch on March 8 after the death of a 49-year-old nurse from “severe bleeding disorders” days after receiving it.

Several other countries also suspend use of doses from the same batch of one million vaccines, which has been delivered to 17 countries.

– List grows –

On Friday Bulgaria suspends the use of the vaccine as it investigates the death of a woman with several underlying conditions who recently received the jab.

An initial probe had suggested the woman died from heart failure and an autopsy found no link with the vaccine.

ALSO READ: Italy court acquits Eni, Shell in Nigeria corruption case

Thailand briefly delays the start of its rollout, but Premier Prayut Chan-O-Cha then receives the jab on Tuesday as the campaign resumes.

And the Democratic Republic of Congo, also due to start administering doses, postpones its campaign citing “precautionary measures”.

Ireland and the Netherlands join the list on Sunday.

– Germany, France, Italy –

Indonesia on Monday says it will “delay” the rollout pending a WHO review into blood clot fears.

In a major development, the German health ministry announces it too is halting the jabs, saying a closer look is necessary.

President Emmanuel Macron follows saying France will suspend use pending a decision on the vaccine’s safety by the European Medicines Agency.

Italy then adds itself to the list, along with Slovenia, Spain, Latvia and Venezuela.

Also on Monday, a health worker in Norway dies of a brain haemorrhage after receiving the vaccine, though no direct link to the jab has been established.

It is the second such fatality within a few days in the country.

On Wednesday Lithuania follows the example of Sweden, Luxembourg and  Cyprus by also suspending use of the vaccine.

[AFP]

Vanguard News Nigeria